🔎 Trials Near Me

Home › Kanser ng Endometrium › Ohio › Cleveland

Pag-aaral pangklinika para sa Kanser ng Endometrium sa Cleveland, OH

Isang pag-aaral para sa Kanser ng Endometrium ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Cleveland. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Nagre-recruitPhase 3
  • Case Western Reserve University, Cleveland
  • UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi ang layo
  • UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22 mi ang layo
Edad 18 pataas · Kababaihan · Na-update Okt 5, 2026 · NCT07198074

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Nagre-recruitPhase 2
  • Case Western Reserve University, Cleveland
  • UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi ang layo
  • UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22 mi ang layo
Lahat ng edad · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Nagre-recruitPhase 1/2
  • The Cleveland Clinic Taussig Cancer Center, Cleveland
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

Nagre-recruitPhase 1
  • Cleveland Clinic Foundation, Cleveland
Edad 18 pataas · Kababaihan · Na-update Okt 2, 2026 · NCT05950464

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Nagre-recruitObservasyonal na pag-aaral
  • Cleveland Clinic, Cleveland
Edad 18 pataas · Kababaihan · Na-update Set 29, 2026 · NCT05051722

Study of AVZO-021 in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1/2
  • Avenzo Therapeutics Recruiting Site, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05867251

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Nagre-recruitPhase 2
  • Case Western Reserve University, Cleveland
  • Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • at 3 pa
Edad 18 pataas · Kababaihan · Na-update Set 28, 2026 · NCT05112601

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Nagre-recruitPhase 2
  • Case Western Reserve University, Cleveland
  • UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi ang layo
  • UH Seidman Cancer Center, Mentor · 22 mi ang layo
Edad 18 pataas · Kababaihan · Na-update Set 24, 2026 · NCT05640999

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Nagre-recruitPhase 1/2
  • UH Cleveland Medical Center, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07109726

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Nagre-recruitObservasyonal na pag-aaral
  • Cleveland Clinic, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05059444

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Nagre-recruitPhase 1
  • Cleveland Clinic Taussig Cancer Institute, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT06774963

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2
  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
  • Cleveland Clinic, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05919264

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1
  • University Hospital - Cleveland Medical Center, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT07444814

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Nagre-recruitPhase 3
  • Research Site, Cleveland
  • Research Site, Cleveland
Edad 18 pataas · Kababaihan · Na-update Hul 29, 2026 · NCT07044336

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Nagre-recruitPhase 1
  • University Hospitals Cleveland Medical Center, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT05208762

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2
  • UH Cleveland Medical Center, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT05768139

First in Human Study of TORL-1-23 in Participants With Advanced Cancer

Nagre-recruitPhase 1
  • Cleveland Clinic, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT05103683

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Cleveland Clinic, Cleveland
Edad 40 pataas · Lahat ng kasarian · Na-update Ene 20, 2026 · NCT05366881

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral
  • Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi ang layo
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Kanser ng Endometrium sa ibang lungsod

Iba pang pag-aaral sa Cleveland

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.